Kloramfenikol Santen

Chloramphenicol, the active ingredient in Kloramfenikol Santen, is an amphenicol presented as an ophthalmic preparation for ocular use. It is employed to treat bacterial eye infections by inhibiting protein synthesis in susceptible microorganisms, providing a broad‑spectrum antibacterial effect for conditions such as conjunctivitis and keratitis.

GNH USA supplies Kloramfenikol Santen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality through rigorous quality‑assurance processes and adherence to EU regulatory standards and reliable delivery timelines.

Chloramphenicol ophthalmic solution is used to manage bacterial infections of the eye and related ocular tissues.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Bacterial keratitis: treats corneal infection caused by susceptible organisms, helping preserve vision. - Blepharitis: controls bacterial overgrowth on eyelid margins, decreasing inflammation. - Post‑operative ocular prophylaxis: prevents bacterial contamination after eye surgery.

Chloramphenicol ophthalmic may cause local and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Transient blurred vision. - Itching or mild discomfort. - Increased tear production. - Temporary stinging after instillation.

Serious or Rare Side Effects: - Allergic reactions such as contact dermatitis or severe ocular inflammation. - Systemic bone‑marrow suppression including aplastic anemia (rare with topical use). - Stevens‑Johnson syndrome or toxic epidermal necrolysis involving the eye. - Severe hypersensitivity leading to swelling or ulceration. - Vision‑threatening corneal ulceration if infection worsens.

When using Kloramfenikol Santen, consider the following precautions.

- Indication confirmation: ensure bacterial etiology before initiating therapy. - Allergy assessment: avoid in patients with known hypersensitivity to chloramphenicol or other amphenicols. - Systemic absorption: limit duration to the shortest effective course to reduce risk of systemic toxicity. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Contact lens wearers: remove lenses before application and wait before reinserting. - Store at room temperature: keep in original container, protect from light and moisture.

Chloramphenicol ophthalmic can interact with certain systemic and topical agents.

Major Interactions (Avoid): - Systemic chloramphenicol: concurrent use may increase systemic exposure and risk of bone‑marrow suppression. - Monoamine oxidase inhibitors: may potentiate hypotensive effects if systemic absorption occurs. - Topical corticosteroids: may mask signs of infection and delay healing.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may increase ocular irritation when used together. - Other ophthalmic antibiotics: simultaneous use can lead to antagonism or reduced efficacy.